MECHANISMS OF LIVER CELL INJURY
MECHANISMS OF LIVER CELL INJURY
批准号:
6517174
负责人:
GREGORY J. GORES
金额:
$24.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2005-03-31
中文摘要
这项建议的总体目标是了解细胞
在肝脏中蓄积的胆盐的机制
胆汁淤积,调节肝细胞凋亡。提出的中心假设是
疏水性肝毒性胆盐通过诱导肝细胞凋亡
Fas依赖的机制,而更亲水的胆盐通过
主动刺激磷脂酰肌醇3-激酶(PI3K)依赖性存活
路径。该提案将使用互补的分子、生化和细胞
确定胆盐如何调节细胞凋亡效应的生物学方法
三个具体目标的过程。具体目标之一将检验该假设
毒性胆盐通过Fas依赖性途径诱导肝细胞凋亡
导致a)不依赖于Fas配体的Fas寡聚;以及b)形成
具有caspase 8激活的死亡诱导信号复合体(DISC)。
具体目标二将检验有毒胆盐增加血浆的假设
膜Fas受体:a)通过依赖于再分布的机制
预先存在的细胞质Fas通过微管依赖到质膜
运输途径;以及b)导致一种依赖于
细胞内Fas转位到细胞表面。具体目标三将
检验无毒、亲水性胆盐直接向细胞发出信号的假设
PI3K依赖机制导致的生存途径:a)激活
抗凋亡的非典型蛋白激酶c亚型;以及b)抑制
非典型PKC依赖的核因子-kappaB激活引起的细胞凋亡
(核因子-kappa B)和/或caspase磷酸化。
英文摘要
The overall objective of this proposal is to understand the cellular
mechanisms by which bile salts, which accumulate in the liver during
cholestasis, modulate hepatocyte apoptosis. The central hypothesis proposed is
that hydrophobic hepatotoxic bile salts induce hepatocyte apoptosis by a
Fas-dependent mechanism while more hydrophilic bile salts inhibit apoptosis by
actively stimulating a phosphoinositide 3-kinase (PI3K)-dependent survival
pathway. The proposal will use complementary molecular, biochemical, and cell
biological approaches to ascertain how bile salts modulate apoptotic effector
processes in three specific aims. Specific aim one will test the hypothesis
that toxic bile salts induce hepatocyte apoptosis by a Fas-dependent process
resulting in a) Fas oligomerization independent of Fas ligand; and b) formation
of a death-inducing signaling complex (DISC) with caspase 8 activation.
Specific aim two will test the hypothesis that toxic bile salts increase plasma
membrane Fas receptors: a) by a mechanism dependent upon a redistribution of
pre-existing cytoplasmic Fas to the plasma membrane via a microtubule-dependent
transport pathway; and b) resulting in a mechanism of apoptosis dependent upon
intracellular Fas translocation to the cell surface. Specific aim three will
test the hypothesis that non toxic, hydrophilic bile salts directly signal cell
survival pathways by a PI3K-dependent mechanism resulting in: a) activation of
anti-apoptotic atypical protein kinase c isoforms; and b) inhibition of
apoptosis by atypical PKC-dependent activation of nuclear factor kappa B
(NF-kappa B) and/or caspase phosphorylation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cholestatic Liver Injury
-
批准号:10372002
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2020
-
负责人:GREGORY J. GORES
-
依托单位:
Cholestatic Liver Injury
-
批准号:10588191
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2020
-
负责人:GREGORY J. GORES
-
依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
-
批准号:10468830
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2018
-
负责人:GREGORY J. GORES
-
依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
-
批准号:10006083
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2018
-
负责人:GREGORY J. GORES
-
依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
-
批准号:10251133
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2018
-
负责人:GREGORY J. GORES
-
依托单位:
Comparative Medicine Core Facility Infrastructure Improvement
-
批准号:7934406
-
项目类别:
-
资助金额:$191.18万
-
财政年份:2010
-
负责人:GREGORY J. GORES
-
依托单位:
Enrichment Program
-
批准号:10630253
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2009
-
负责人:GREGORY J. GORES
-
依托单位:
Enrichment Program
-
批准号:10200781
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2009
-
负责人:GREGORY J. GORES
-
依托单位:
Enrichment Program
-
批准号:10438739
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2009
-
负责人:GREGORY J. GORES
-
依托单位:
LONG-ACTING OCTREOTIDE IN THE TREATMENT OF PATIENTS
-
批准号:7206098
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2005
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:8250599
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:6595118
-
项目类别:
-
资助金额:$28.03万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:6942769
-
项目类别:
-
资助金额:$24.78万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7069491
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7840512
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7569503
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:8075463
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:8846590
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Long-acting octreotide in treatment of advnced HCC
-
批准号:7042302
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7233296
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: